Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000233705 | SCV000284328 | benign | Gorlin syndrome | 2024-04-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001015015 | SCV001175799 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-09-26 | criteria provided, single submitter | clinical testing | The p.T768I variant (also known as c.2303C>T), located in coding exon 15 of the PTCH1 gene, results from a C to T substitution at nucleotide position 2303. The threonine at codon 768 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005044474 | SCV005679694 | uncertain significance | Basal cell carcinoma, susceptibility to, 1; Holoprosencephaly 7; Basal cell nevus syndrome 1 | 2024-06-22 | criteria provided, single submitter | clinical testing |